Guy Czaykowski
Psychiatry · Daytona Beach, FLNPI 1659429223
Payments from drug & device makers
Across 378 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$2K
- Johnson & Johnson$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$878
- AbbVie$414
- Neurocrine Biosciences, Inc.$377
- plus $1K from 8 others
What the payments were for
- Food & beverage$7,88197%
- Education$2553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 122 | $2,357 |
| Alkermes, Inc. | 71 | $1,915 |
| Johnson & Johnson | 42 | $1,017 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 45 | $878 |
| AbbVie(2 entities) | 23 | $414 |
| Neurocrine Biosciences, Inc. | 16 | $377 |
| E.r. Squibb & Sons, L.L.C. | 12 | $366 |
| Otsuka America Pharmaceutical, Inc. | 21 | $328 |
| Indivior Inc. | 14 | $283 |
| Sunovion Pharmaceuticals Inc. | 5 | $80 |
| Lundbeck LLC | 3 | $46 |
| Eisai Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$916
- LYBALVI$888
- INVEGA SUSTENNA$250
- AUSTEDO$248
- Austedo XR$244
- ARISTADA INITIO$229
- COBENFY$127
- INVEGA TRINZA$125
- INGREZZA$124
- SPRAVATO$116
- CAPLYTA$104
How this compares
$8,135 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 244 | $711,345 |
| UzedyRisperidone | 83 | $373,978 |
| AustedoDeutetrabenazine | 13 | $199,662 |
| LybalviOlanzapine/Samidorphan Malate | 58 | $87,950 |
| AristadaAripiprazole Lauroxil | 17 | $51,208 |
| CaplytaLumateperone Tosylate | 31 | $49,746 |
| VraylarCariprazine Hcl | 34 | $45,102 |
| Risperdal ConstaRisperidone Microspheres | 13 | $33,015 |
| Clozapine | 191 | $17,586 |
| TrintellixVortioxetine Hydrobromide | 16 | $7,817 |
| Olanzapine OdtOlanzapine | 124 | $7,009 |
| Clozapine OdtClozapine | 26 | $6,719 |
| Olanzapine | 135 | $4,832 |
| Paliperidone ErPaliperidone | 54 | $4,769 |
| Divalproex Sodium ErDivalproex Sodium | 149 | $4,079 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $1,017 | $744,360257 claims |
| Teva Pharmaceuticals USA, Inc.Uzedy, Austedo | $2,357 | $573,64096 claims |
| Alkermes, Inc.Lybalvi, Aristada | $1,915 | $139,15875 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $878 | $49,74631 claims |
| AbbVieVraylar | $414 | $45,10234 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $17 | $7,81716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Daytona Beach
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.